Pancreatic neuroendocrine neoplasms: 2020 update on pathologic and imaging findings and classification

L Khanna, SR Prasad, A Sunnapwar, S Kondapaneni… - Radiographics, 2020 - pubs.rsna.org
Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with
neuroendocrine differentiation that show characteristic clinical, histomorphologic, and …

[HTML][HTML] Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer

J Swierczynski, A Hebanowska… - World journal of …, 2014 - ncbi.nlm.nih.gov
There is growing evidence that metabolic alterations play an important role in cancer
development and progression. The metabolism of cancer cells is reprogrammed in order to …

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

J van Riet, HJG van de Werken, E Cuppen… - Nature …, 2021 - nature.com
Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) form clinically and
genetically heterogeneous malignancies, characterized by distinct prognoses based upon …

1, 3, 4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents

S Bajaj, V Asati, J Singh, PP Roy - European journal of medicinal chemistry, 2015 - Elsevier
Abstract Five member heterocyclic 1, 3, 4-oxadiazole nucleus find unique place in medicinal
chemistry and plays significant role in producing anticancer activity. The small and simple 1 …

[PDF][PDF] The Daxx/Atrx complex protects tandem repetitive elements during DNA hypomethylation by promoting H3K9 trimethylation

Q He, H Kim, R Huang, W Lu, M Tang, F Shi, D Yang… - Cell stem cell, 2015 - cell.com
In mammals, DNA methylation is essential for protecting repetitive sequences from aberrant
transcription and recombination. In some developmental contexts (eg, preimplantation …

[HTML][HTML] Gastrinoma

RT Jensen, T Ito - Endotext [Internet], 2023 - ncbi.nlm.nih.gov
Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …

[HTML][HTML] Cardio-metabolic indices and metabolic syndrome as predictors of clinical severity of gastroenteropancreatic neuroendocrine tumors

L Barrea, G Muscogiuri, R Modica, B Altieri… - Frontiers in …, 2021 - frontiersin.org
Background Obesity, mainly visceral obesity, and metabolic syndrome (MetS) are major risk
factors for the development of type 2 diabetes, cardiovascular diseases, and cancer. Data …

Oridonin inhibits the migration and epithelial‐to‐mesenchymal transition of small cell lung cancer cells by suppressing FAK‐ERK1/2 signalling pathway

L Xu, Y Bi, Y Xu, Z Zhang, W Xu… - Journal of cellular …, 2020 - Wiley Online Library
Small cell lung cancer (SCLC) is a severe malignant with high morbidity; however, few
effective and secure therapeutic strategy is used in current clinical practice. Oridonin is a …

Targeting β-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours

X Jiang, Y Cao, F Li, Y Su, Y Li, Y Peng… - Nature …, 2014 - nature.com
Inactivating MEN1 mutations are the most common genetic defects present in sporadic and
inherited pancreatic neuroendocrine tumours (PNETs). The lack of interventional therapies …

The evolving (epi) genetic landscape of pancreatic neuroendocrine tumours

CP Pipinikas, AM Berner, T Sposito… - Endocrine-related …, 2019 - erc.bioscientifica.com
Neuroendocrine neoplasms (NENs) are a relatively rare group of heterogeneous tumours
originating from neuroendocrine cells found throughout the body. Pancreatic NENs …